Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1801 AL 1815

Squalamine and Its Aminosterol Derivatives: Overview of Biological Effects and Mechanisms of Action of Compounds with Multiple Therapeutic Applications

Mammari N, Salles E, Beaussart A, El-Kirat-Chatel S, Varbanov M.

Microorganisms. 2022 Jun 13;10(6):1205. doi: 10.3390/microorganisms10061205.

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease

Rahman MU, Bilal M, Shah JA, Kaushik A, Teissedre PL, Kujawska M.

Pharmaceutics. 2022 Jun 13;14(6):1252. doi: 10.3390/pharmaceutics14061252.

Objective Measurement of Walking Activity Using Wearable Technologies in People with Parkinson Disease: A Systematic Review

Correno MB, Hansen C, Carlin T, Vuillerme N.

Sensors (Basel). 2022 Jun 16;22(12):4551. doi: 10.3390/s22124551.

A pathologically confirmed case of combined amyotrophic lateral sclerosis with C9orf72 mutation and multiple system atrophy

King A, Lee YK, Jones S, Troakes C.

Neuropathology. 2022 Aug;42(4):302-308. doi: 10.1111/neup.12808. Epub 2022 Jun 23.

Triggers for Referral to Specialized Palliative Care in Advanced Neurologic and Neurosurgical Conditions: A Systematic Review

McConvey K, Kazazian K, Iansavichene AE, Jenkins ME, Gofton TE.

Neurol Clin Pract. 2022 Jun;12(3):190-202. doi: 10.1212/CPJ.0000000000001159.

Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Glenardi G, Handayani T, Barus J, Mangkuliguna G.

Neurol Clin Pract. 2022 Apr;12(2):139-148. doi: 10.1212/CPJ.0000000000001143.

Epigallocatechin gallate for Parkinson's disease

Sergi CM.

Clin Exp Pharmacol Physiol. 2022 Oct;49(10):1029-1041. doi: 10.1111/1440-1681.13691. Epub 2022 Jul 23.

Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies

Bramich S, King A, Kuruvilla M, Naismith SL, Noyce A, Alty J.

J Neurol. 2022 Sep;269(9):4684-4695. doi: 10.1007/s00415-022-11213-9. Epub 2022 Jun 24.

Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming

Legault EM, Bouquety J, Drouin-Ouellet J.

Cell Reprogram. 2022 Oct;24(5):228-251. doi: 10.1089/cell.2021.0172. Epub 2022 Jun 24.

Prevalence and clinical aspects of depression in Parkinson's disease: A systematic review and meta‑analysis of 129 studies

Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S.

Neurosci Biobehav Rev. 2022 Oct;141:104749. doi: 10.1016/j.neubiorev.2022.104749. Epub 2022 Jun 21.

A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson's disease

Zhong Y, Liu H, Liu G, Zhao L, Dai C, Liang Y, Du J, Zhou X, Mo L, Tan C, Tan X, Deng F, Liu X, Chen L.

NPJ Parkinsons Dis. 2022 Jun 24;8(1):82. doi: 10.1038/s41531-022-00347-2.

The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic

Tan AH, Lim SY, Lang AE.

Nat Rev Neurol. 2022 Aug;18(8):476-495. doi: 10.1038/s41582-022-00681-2. Epub 2022 Jun 24.

Can the administration of platelet lysates to the brain help treat neurological disorders?

Nebie O, Buée L, Blum D, Burnouf T.

Cell Mol Life Sci. 2022 Jun 24;79(7):379. doi: 10.1007/s00018-022-04397-w.

Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Meng W, Kang F, Dong M, Wang S, Han M, Huang X, Wang S, Li J, Yang C.

BMC Anesthesiol. 2022 Jun 24;22(1):197. doi: 10.1186/s12871-022-01735-0.

Sleep and affective disorders in relation to Parkinson's disease risk among older women from the Women's Health Initiative

Beydoun HA, Chen JC, Saquib N, Naughton MJ, Beydoun MA, Shadyab AH, Hale L, Zonderman AB.

J Affect Disord. 2022 Sep 1;312:177-187. doi: 10.1016/j.jad.2022.06.031. Epub 2022 Jun 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias